Scynexis (SCYX) Change in Cash (2013 - 2026)
Scynexis (SCYX) posted Change in Cash of $15.4 million for Q1 2026, up 138.5% on a QoQ basis from $6.5 million in Q4 2025, and up 269.2% year-over-year from $4.2 million in Q1 2025.
Scynexis (SCYX) Change in Cash (2013 - 2026) Analysis & Trends
Scynexis' Change in Cash history runs 14 years deep, the most recent figure standing at $15.4 million for Q1 2026.
- Quarterly Change in Cash rose 269.2% year-over-year to $15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.4 million (up 202.93% YoY) and the FY2025 annual result came in at $4.9 million, up 126.96% from the prior year.
- Change in Cash was $15.4 million for Q1 2026 at Scynexis, up from $6.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $31.4 million in Q2 2023 and bottomed at -$50.1 million in Q3 2022.
- A 5-year average of -$4.0 million and a median of -$9.1 million in 2025 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash plunged 800.39% — and 2026, when it jumped 269.2%.
- Scynexis' Change in Cash stood at -$22.8 million in 2022, then soared by 56.06% to -$10.0 million in 2023, then slipped by 26.51% to -$12.7 million in 2024, then surged by 150.97% to $6.5 million in 2025, then soared by 138.5% to $15.4 million in 2026.
- Business Quant data shows SCYX's Change in Cash at $15.4 million in Q1 2026, $6.5 million in Q4 2025, and $3.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 15.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.41 Mn |
| Dec 31, 2025 | 6.46 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | -9.11 Mn |
| Dec 31, 2024 | -12.68 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | -9.49 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | -10.02 Mn |
| Sep 30, 2023 | -13.89 Mn |
| Jun 30, 2023 | 31.37 Mn |
| Mar 31, 2023 | -18.90 Mn |
| Dec 31, 2022 | -22.81 Mn |
| Sep 30, 2022 | -50.07 Mn |
| Jun 30, 2022 | 23.48 Mn |
| Mar 31, 2022 | -9.27 Mn |
| Dec 31, 2021 | 4.38 Mn |
| Sep 30, 2021 | -12.39 Mn |
| Jun 30, 2021 | 20.43 Mn |